Minoryx Therapeutics
Develops novel therapies for pediatric genetic diseases
Total raised
€74M
€73,500,000
Funding rounds
4
Investors
6
distinct backers
Active since
2013-03
latest 2022-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood21
base rate 51% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €30M+ raised
- ▲ 15y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-05-31 | Series C | €51M | Caixa Capital Risc,Columbus Venture Partners,FundPlus,Ysios Capital | View deal → |
| 2015-10-01 | Series A | €19M | Caixa Capital Risc,IDInvest Partners,Ysios Capital | View deal → |
| 2015-01-01 | Early VC | €1.6M | Caixa Capital Risc | View deal → |
| 2013-04-01 | Series A | €1.5M | Caixa Capital Risc,Inveready | View deal → |
Investors
6Related news
- Minoryx Raises EUR 51M in Series C Fundingfinsmes.com · 2022-05
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel